Skip to content

To Study the clinical Effect of Haridradi kashay ghana vati and Kaishor Guggul in Dadru (Tinea Corporis) in 62 patients.

An open randomized comparative clinical study to evaluate the efficacy of Ghanvati of Haridradi kashay and Kaishore guggul in the management of Dadru. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077186
Enrollment
62
Registered
2024-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Priya Manoj Gidwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age: 18 to 80 years. 2) Sex: All Genders 3) Patient with classical signs and symptoms of Dadru like Kandu, Pidika, Raga and Daha. 4) Understanding and willing to sign the informed consent form. 5) Chronicity of disease should be less than 2 years. 6) Area of lesion up to 25cm sq.

Exclusion criteria

Exclusion criteria: 1. Patients having skin lesions other than Dadrukushta (Tinea corporis) like Eczema, psoriasis, urticaria etc. 2. Pregnancy and lactating mother. 3. Immuno-compromised patients like AIDS (HIV positive), HbSAg positive etc. 4. Chronicity of disease more than 2 years.

Design outcomes

Primary

MeasureTime frame
size of lesion number of lesionTimepoint: 28 days

Secondary

MeasureTime frame
1)Kandu (Itching) 2) Raga (Erythema) 3) Pidka (papule) 4) Daha (burning)Timepoint: 28 days

Countries

India

Contacts

Public ContactDr Hemant Paradkar

APMs Ayurved Mahavidyalaya, Sion

hemant.paradkar@gmail.com9987519315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026